These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6889694)

  • 1. Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor.
    Bever CT; Chang HW; Penn AS; Jaffe IA; Bock E
    Neurology; 1982 Oct; 32(10):1077-82. PubMed ID: 6889694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the pathophysiology of chronic D-penicillamine-induced myasthenia.
    Burres SA; Kanter ME; Richman DP; Arnason BG
    Ann N Y Acad Sci; 1981; 377():640-51. PubMed ID: 6951489
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor.
    Takamori M; Okumura S; Nagata M; Yoshikawa H
    J Neurol Sci; 1988 Jun; 85(2):121-9. PubMed ID: 3260271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myasthenia gravis induced by D-penicillamine in a patient with progressive systemic sclerosis].
    Marchiori PE; Scaff M; Cossermelli W; De Assis JL
    Arq Neuropsiquiatr; 1984 Dec; 42(4):380-3. PubMed ID: 6535556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of penicillamine-induced myasthenia gravis.
    Kuncl RW; Pestronk A; Drachman DB; Rechthand E
    Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
    Almon RR; Andrew CG; Appel SH
    Science; 1974 Oct; 186(4158):55-7. PubMed ID: 4421998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented anti-acetylcholine receptor response following long-term penicillamine administration.
    Bever CT; Dretchen KL; Blake GJ; Chang HW; Penn AS; Asofsky R
    Ann Neurol; 1984 Jul; 16(1):9-13. PubMed ID: 6431900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor.
    Russell AS; Lindstrom JM
    Neurology; 1978 Aug; 28(8):847-9. PubMed ID: 567304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
    Merlie JP; Heinemann S; Einarson B; Lindstrom JM
    J Biol Chem; 1979 Jul; 254(14):6328-32. PubMed ID: 447717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
    Takamori M; Ishii N; Tsujihata M; Mori M; Kasai M
    No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of myasthenia gravis antibodies to different acetylcholine receptor preparations.
    Zielinski A; Brenner T; Abramsky O
    Isr J Med Sci; 1982 Apr; 18(4):483-6. PubMed ID: 7085248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine receptor antibodies in penicillamine-induced myasthenia gravis.
    Bocanegra TS; Espinoza LR; Vasey FB; Germain BF; Jaffe IA; Penn AS
    JAMA; 1981 Oct 23-30; 246(17):1901. PubMed ID: 7288965
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-acetylcholine receptor antibodies in D-penicillamine-associated myasthenia gravis.
    Vincent A; Newsom-Davis J; Martin V
    Lancet; 1978 Jun; 1(8076):1254. PubMed ID: 78009
    [No Abstract]   [Full Text] [Related]  

  • 20. The in vitro effects of D-penicillamine upon anti-AChR production by thymic and peripheral blood lymphocytes from patients with myasthenia gravis.
    Scadding GK; Calder L; Newsom-Davis J
    Muscle Nerve; 1983; 6(9):656-60. PubMed ID: 6606776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.